Renal ultrastructural alterations induced by various preparations of mefenamic acid

Qais Bashir Jarrar1,2, Muhammad Nazrul Hakim2, Zainul Amiruddin Zakaria2

  • 1Department of Applied Pharmaceutical Sciences, Faculty of Pharmacy, Al-Isra University, Amman, Jordan.

Ultrastructural Pathology
|January 23, 2020
PubMed

Insights

Mefenamic acid (MFA) can cause kidney damage. A study found that MFA-DDC liposomes caused fewer cellular changes in rat kidneys compared to free MFA, suggesting safer drug delivery.

Area of Science:

  • Nephrology
  • Pharmacology
  • Cell Biology

Background:

  • Mefenamic acid (MFA) is a nonsteroidal anti-inflammatory drug known to cause renal toxicity.
  • Understanding the cellular mechanisms of MFA-induced kidney damage is crucial for developing safer drug formulations.

Purpose of the Study:

  • To investigate the ultrastructural alterations in renal tissues induced by different mefenamic acid (MFA) preparations.
  • To compare the nephrotoxic potential of free MFA, MFA-Tween 80 liposomes, and MFA-DDC liposomes.

Main Methods:

  • Sprague-Dawley rats received daily doses of free MFA, MFA-Tween 80 liposomes, or MFA-DDC liposomes for 28 days.
  • Renal biopsies were examined using transmission electron microscopy to assess ultrastructural changes.

Main Results:

  • MFA preparations induced mitochondrial injury, nuclear and lysosomal alterations, tubular cell steatosis, apoptosis, autophagy, and nucleophagy.
  • These renal alterations were more pronounced with free MFA and MFA-Tween 80 liposomes compared to MFA-DDC liposomes.

Conclusions:

  • Mefenamic acid-DDC liposomes demonstrate a reduced potential for inducing renal damage compared to free MFA and MFA-Tween 80 liposomes.
  • MFA-DDC liposomes may represent a safer alternative for drug delivery, minimizing nephrotoxicity.